Georgia Code
Chapter 22 - Clinical Laboratories
§ 31-22-1. Definitions

As used in this chapter, the term:
History. Ga. L. 1970, p. 531, § 2; Ga. L. 1971, p. 247, § 1; Ga. L. 1982, p. 1081, §§ 1, 2, 6, 7; Ga. L. 1991, p. 94, § 31; Ga. L. 1991, p. 349, § 1; Ga. L. 2005, p. 1190, § 1/SB 51; Ga. L. 2009, p. 453, § 1-5/HB 228; Ga. L. 2011, p. 705, § 4-16/HB 214; Ga. L. 2016, p. 318, § 1/SB 273; Ga. L. 2017, p. 547, § 1/HB 210; Ga. L. 2021, p. 472, § 1/HB 93.
The 2017 amendment, effective July 1, 2017, in the middle of the first sentence of paragraph (2), deleted “shall include” preceding “blood banks”, and substituted “unless such human blood and its component parts are intended as source material for the manufacture of biological products and regulated by the Center for Biologics Evaluation and Research (CBER) within the federal Food and Drug Administration; the term ‘clinical laboratory’ shall include” for “as well as”.
The 2021 amendment, effective July 1, 2021, rewrote this Code section.
Law reviews.
For article on the 2011 amendment of this Code section, see 28 Ga. St. U.L. Rev. 147 (2011).

Structure Georgia Code